Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adult greater than 18 years |
Dose: Inhaler – 1 or 2 inhalations Frequency: twice daily Note: Maximum daily dose: 4 inhalations. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: less than 18 years |
Dose: Not established Note: Safety and efficacy not established |
Administration
- Shake well before use
- Rinse mouth after use
Side Effect
- Common Pharyngitis
- Uncommon Influenza
- oral fungal infection
- pharyngeal and oesophageal candidiasis
- vaginal candidiasis
- gastroenteritis
- sinusitis
- Uncommon Granulocytopenia
- Very Rare Thrombocytopenia
- Uncommon Allergic dermatitis
- erythema
- lips
- face
- eye and pharyngeal oedema
- Very Rare Adrenal suppression
- Uncommon Hypokalaemia
- hyperglycaemia
- Uncommon Restlessness
- Very Rare Abnormal behaviour
- sleep disorder
- hallucination
- Common Headache
- Uncommon Tremor
- dizziness
- Very Rare Glaucoma
- cataract
- Uncommon Otosalpingitis
- Uncommon Palpitations
- prolonged ECG QT corrected interval
- ECG change
- tachycardia
- tachyarrhythmia
- Rare Ventricular extrasystoles
- angina pectoris
- Very Rare Atrial fibrillation
- Vascular Disorders Uncommon Hyperaemia
- flushing
- Thoracic and Mediastinal Disorders Common Dysphonia
- Uncommon Rhinitis
- cough
- productive cough
- throat irritation
- asthmatic crisis
- Rare Paradoxical bronchospasm
- Very Rare Dyspnoea
- exacerbation of asthma
- Uncommon Diarrhoea
- dry mouth
- dyspepsia
- dysphagia
- burning sensation of the lips
- nausea
- dysgeusia
- Uncommon Pruritus
- rash
- hyperhidrosis
- Rare Urticaria
- angioneurotic oedema
- Uncommon Muscle spasms
- myalgia
- Very Rare Growth retardation in children and adolescents
- Rare Nephritis
- Very Rare Peripheral oedema
- Uncommon Increased C-reactive protein
- platelet count
- free fatty acids
- blood insulin
- blood ketone body
- Rare Increased or decreased blood pressure
- Very Rare Decreased bone density
- As with other inhalation therapy, paradoxical bronchospasm may occur
- Hypokalaemia
- headache
- tremor
- palpitations
- cough
- muscle spasms and prolongation of QTc interval
- Oral fungal infections and candidiasis
- dysphonia
- throat irritation
- Dysphonia and candidiasis may be relieved by gargling or rinsing the mouth with water or brushing the teeth after using Innovair
- Symptomatic candidiasis can be treated with topical antifungal therapy while continuing the treatment with Innovair
- adrenal suppression
- decrease in bone mineral density
- growth retardation in children and adolescents
- cataract and glaucoma
- rash
- urticaria pruritus
- erhythema and oedema of the eyes, face, lips and throat may also occur
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
β-blockers
|
Effect of formoterol may be reduced
|
|
β-adrenergic drugs
|
May increase the effects of formoterol
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Prior to dispensing to the patient: Store in a refrigerator (2-8°C) (for a maximum of 15 months). After dispensing: Store at temperatures not exceeding 30°C (for a maximum of 2 months).
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.